Biotech and Pharma Patents at the Supreme Court and Federal Circuit: Top 10 Cases of 2012

To access a recording of this webinar or receive a copy of the slides, please contact [email protected].

Robert will provide their views on several federal court decisions including:

• section 101 patent eligibility under Mayo
• patentability of human genes under Myriad
• the exhaustion doctrine for self-replicating technologies under Bowman
• reverse payments in ANDA cases in view of Merck

He will put these cases into context and provide important advice on how they may impact both your prosecution and litigation strategies.

Speakers:

• Robert Sullivan, Jr., Principal – New York